Search results
Results from the WOW.Com Content Network
This "formally initiates the litigation process under the Hatch-Waxman Act and triggers a 30-month stay of any potential FDA approval for Sun Pharma's ANDA," Mayne Pharma said in a statement.
Sun Pharmaceutical Industries Ltd. was established by Dilip Shanghvi in 1983 in Calcutta, West Bengal with five psychiatry products and a two-person marketing team. Today it is ranked number one in share of prescriptions with 12 classes of doctors in India and a market leader in Psychiatry, Neurology, Cardiology, Orthopaedics, Gastroenterology, Nephrology, Diabetology, Dermatology, Urology ...
This is an accepted version of this page This is the latest accepted revision, reviewed on 15 November 2024. Indian Businessman Dilip Shanghvi Born (1955-10-01) 1 October 1955 (age 69) Amreli, Gujarat, India Alma mater Bhawanipur Education Society College, University of Calcutta Occupation(s) Founder and MD of Sun Pharmaceuticals Spouse Vibha Shanghvi Children 2 Dilip Shanghvi (born 1 October ...
Discover the latest breaking news in the U.S. and around the world — politics, weather, entertainment, lifestyle, finance, sports and much more.
The pharmaceutical industry, grappling with new government limits on drug prices, is focusing its requests for president-elect Donald Trump and Congress on "fixing" a Biden-era law allowing the ...
DUSA Pharmaceuticals, Inc., owned by Sun Pharma, is a pharmaceutical company with dermatology products, including Levulan and Nicomide. In the first quarter of 2006, DUSA Pharmaceuticals obtained Sirius Laboratories in a merger estimated to be worth 30 million dollars.
HYDERABAD, India (Reuters) -At least 15 people were killed in an explosion on Wednesday at a pharmaceuticals manufacturing plant in southern India's Andhra Pradesh state, a district government ...
Main page; Contents; Current events; Random article; About Wikipedia; Contact us; Pages for logged out editors learn more